Consideration of sex and gender in Cochrane reviews of interventions for preventing healthcare-associated infections: a methodology study
- PMID: 30876452
- PMCID: PMC6419810
- DOI: 10.1186/s12913-019-4001-9
Consideration of sex and gender in Cochrane reviews of interventions for preventing healthcare-associated infections: a methodology study
Abstract
Background: Healthcare-associated infections (HAIs) are common and increase morbidity, mortality, and healthcare costs. Their control continues to be an unresolved issue worldwide. HAIs epidemiology shows sex/gender differences. Thus the lack of consideration of sex/gender in Cochrane reviews will limit their applicability and capacity to support informed decisions. This study aims to describe the extent to which Cochrane reviews of interventions for preventing HAIs consider sex and gender.
Methods: Methodology study appraising Cochrane reviews of interventions to prevent HAIs.
Search methods: Cochrane Database of Systematic Reviews from 1995 (launch of the journal) to 31 December 2016. Two authors independently extracted data with EPPI-Reviewer 4 software, and independently appraised the sex/gender content of the reviews with the Sex and Gender Appraisal Tool for Systematic Reviews (SGAT-SR).
Results: This study included 113 reviews assessing the effects of interventions for preventing HAIs. 100 reviews (88%) used at least one sex or gender-related term. The terminology used was heterogeneous, being "sex" the term used in more reviews (51%). No review defined neither sex nor gender. Thus we could not assess the definitions provided. Consideration of sex and gender was practically absent in the included reviews; in fact, no review met all the applicable items of the SGAT-SR, and 51 reviews (50%) fulfilled no item. No review provided a complete description of the sex and the gender of the samples of the included studies. Only ten reviews (10%) planned to perform sex- and gender-based analysis and only three (3%) could complete the analysis. The method chosen was always the subgroup analysis based on sex (one review) or gender (two reviews). Three reviews (3%) considered sex or gender-related findings in the conclusions.
Conclusion: Consideration of sex and gender in Cochrane reviews of interventions for preventing HAIs was practically absent. This lack of attention to sex and gender reduces the quality of Cochrane reviews, and their applicability for all people: women and men, boys and girls, and people of diverse gender identities. Cochrane should attempt to address the shortfalls detected.
Keywords: Cochrane; Data extraction; Equity; Gender; Gender bias; Healthcare-associated infection; Sex; Sex/gender; Systematic reviews.
Conflict of interest statement
Authors’ informations
JLA is a PhD candidate in Methodology of Biomedical Research and Public (Department of Paediatrics, Obstetrics & Gynaecology and Preventative Medicine at the Universitat Autònoma de Barcelona, Spain). This study is part of his PhD.
SCN, as part of her dissertation for the
The SEXCOMPLEX Working Group leads the two-year project (2017–2019) titled “Influence of sex and sex hormones on human chronic disorders of complex etiology” (SEXCOMPLEX). The project is coordinated by
We published a prior abstract (less than 400 words) and poster presenting the preliminary results of this study as part of Global Evidence Summit, Cape Town, South Africa (2017) [117].
Ethics approval and consent to participate
Not applicable. The Ethics Committee of
Consent for publication
Not applicable. The manuscript does not contain data from any individual person.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- Health Impact Assessment (HIA) - Glossary of terms used. Available from: http://www.who.int/hia/about/glos/en/index1.html.
-
- Inequity and inequality in health. Available from: http://www.globalhealtheurope.org/index.php/resources/glossary/values/17....
-
- Welch V, Petticrew M, Ueffing E, Benkhalti Jandu M, Brand K, Dhaliwal B, Kristjansson E, Smylie J, Wells GA, Tugwell P. Does consideration and assessment of effects on health equity affect the conclusions of systematic reviews? A methodology study. PLoS One. 2012;7:e31360. doi: 10.1371/journal.pone.0031360. - DOI - PMC - PubMed
-
- Petkovic J, Welch V, Jull J, Petticrew M, Kristjansson E, Rader T, Yoganathan M, McGowan J, Lyddiatt A, Grimshaw JM, et al. How health equity is reported and analyzed in randomized trials (Protocol). Cochrane Database Syst Rev. 2017:MR000046. 10.1002/14651858.MR000046.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
